CADASIL Connection Webinar Speaker Series Announcement


Blog Archives:

CADASIL Connection Webinar Speaker Series Announcement

Exciting progress is being made in understanding mechanisms of CADASIL mutations in disease expression, leading to identification of potential disease-modifying therapeutics and disease biomarkers.
To highlight these advancements cureCADASIL Association is hosting
CADASIL Connection
an online series of three informative webinars that will be unique opportunities to educate and connect the audience of researchers, clinicians, and patients on current research and developments in CADASIL.
Our first webinar will be held via webconference:
Tuesday, August 1, 2017 at 7:00 – 8:30 p.m. (EST)
Registration available at: 

After registering, you will receive a confirmation email with information about joining the webinar.

After the webinar, a recording will be available at cureCADASIL.org.

 Irene Griswold-Prenner, Ph.D.
cureCADASIL SAB member and Co-founder & Chief Scientific Officer of Imago Pharmaceuticals, will kick-off the series with an overview of the known potential therapeutics for CADASIL that are in early proof-of-concept stage.

 

Li-Ru Zhao, Ph.D., M.D.
tenured Associate Professor, Department of Neurosurgery, State University of New York (SUNY) Upstate Medical University, recipient of the 2017 Bernard Sanberg Memorial Award from the American Society for Neural Therapy and Repair, will present:

Exploring a therapeutic approach for CADASIL:

                          The efficacy of bone marrow stem cell factors in brain repair

cureCADASIL spotlighted by Rare Disease Report

Rare Disease Report is a website and weekly e-newsletter that offers an independent voice for the Rare Disease Community. It strives to bring together medical, scientific, investment, regulatory, and advocate professionals interested in rare diseases and orphan drugs. Recently the work done by cureCADASIL was spotlighted by RDR.  We are excited for this opportunity to share our programs with the rare disease community.

Spotlight on CureCADASIL

Ruth J Hickman, MD
Published Online: Saturday, Apr 23, 2016

“CureCADASIL (also known as CADASIL Association) is a nonprofit group dedicated to raising awareness of the rare disease cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Through the aims of communication, advocacy, research, and education, CureCADASIL is working to improve the lives of those affected by the disease.”

 

This is just the introductory part of the article. Please read the full article spotlighting cureCADASIL at this link:

http://www.raredr.com/news/spotlight-on-curecadasil